Cellectis S.A. Stock Other OTC
Equities
CMVLF
FR0010425595
Biotechnology & Medical Research
Sales 2024 * | 18.49M 20.06M | Sales 2025 * | 54.71M 59.35M | Capitalization | 245M 266M |
---|---|---|---|---|---|
Net income 2024 * | -54M -58.58M | Net income 2025 * | -80M -86.78M | EV / Sales 2024 * | 4.41 x |
Net cash position 2024 * | 163M 177M | Net cash position 2025 * | 88.23M 95.71M | EV / Sales 2025 * | 2.86 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.92% |
Latest transcript on Cellectis S.A.
Managers | Title | Age | Since |
---|---|---|---|
David Sourdive
FOU | Founder | 57 | 99-12-19 |
André Choulika
FOU | Founder | 59 | 99-12-19 |
Arthur Stril
DFI | Director of Finance/CFO | 35 | 18-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 75 | 20-11-04 | |
André Choulika
FOU | Founder | 59 | 99-12-19 |
David Sourdive
FOU | Founder | 57 | 99-12-19 |
1st Jan change | Capi. | |
---|---|---|
+52.36% | 58.06B | |
-3.86% | 40.53B | |
+36.22% | 38.99B | |
-12.01% | 26.56B | |
+14.13% | 26.7B | |
-21.62% | 18.98B | |
+0.21% | 12.17B | |
+25.96% | 11.92B | |
+23.02% | 12B |